• <blockquote id="2as0w"></blockquote>
      Final Products
      Intermediates of Larotrectinib(LOXO-101)
      Intermediates of Ivabradine
      Intermediates of Dacomitinib
      Intermediates of Efinaconazole
      Intermediates of Olodaterol
      Intermediates of Ticagrelor
      Intermediates of Entrectinib
      Intermediates of Acotiamide
      Intermediates of Dofetilide
      Piperazine derivative
      Piperidine derivative
      Pyrrolidine derivative
      Pyridine derivative
      Other Intermediates
      Intermediates of Mirabegron
      Intermediates of Tiotropium Bromide
      Intermediates of Vilanterol
      Intermediates of Umeclidinium bromide
      Intermediates of Glycopyrrolate Bromide
      Intermediates of Donepezil HCI
        News Center


      The leadership of the reform and innovation department of the provincial development and Reform Commission and the Science Center came to our company to research [2017/10/25]
      The expert group of the provincial science and Technology Department came to our unit for the research and investigation of the high level scientific and technological talent team [2017/10/17]
      The opening ceremony of Anhui Dexinjia modern heterocyclic drugs (intermediates) joint research and development center and the practical teaching base of HeFei University of Technology is held ceremon [2017/10/16]
      Pan Dianhua, Vice Minister of the municipal Party Committee Organization Department, came to our company to research personnel work [2017/10/12]
      The company successfully passed the Jewish certification [2017/10/19]
      Major events of the company in 2017 [2017/10/11]
      Our company won the outstanding enterprise in the bio-pharmaceutical industry finals of the Sixth China Innovation and Entrepreneurship Competition [2017/09/19]
      Nanchang helioeast pharmaceutical limited company visited our company and signed a project cooperation agreement [2017/09/10]
      Our unit has been evaluated as "key cultivation brand enterprise" in Fuyang [2017/08/25]
      Our unit approved "Anhui heterocyclic characteristic Drug Technology Engineering Research Center" [2017/08/15]
      Our team achieved excellent results in the China Innovation and entrepreneurship competition Anhui division finals [2017/08/11]
      The company was shortlisted for the Sixth China Innovation and entrepreneurship competition in Anhui final [2017/07/20]
      Our company has been appraised as Fuyang's major specialized special new small and medium-sized enterprise [2017/06/20]
      Qi Anmin,the director of Standing Committee of the county people's Congress,came to our company to investigate [2017/05/11]
      Ren Ming ,member of the provincial science and technology Department Party group and inspector came to our company to investigate and guide scientific and technological innovation work [2017/04/20]

      28 Records 12
      Copyright(C)2017 , Jinan Dexinjia Bio&Tech Co.,Ltd. All Rights Reserved.  Supported by  ChemNet  ChinaChemNet Toocle Copyright Notice
    • <blockquote id="2as0w"></blockquote>